embecta
Develops and manufactures insulin delivery devices for diabetes care.
Company facts
- Founded
- 1924
- Employees
- 2,000
- Headquarters
- United States
- CEO
- Devdatt (Dev) Kurdikar
- Type
- Public
- Listed
- NASDAQ: EMBC
About
At embecta, we have a singular focus: improving the lives of people living with diabetes. With a rich legacy of nearly 100 years in insulin delivery, we are proud to be a global medical technology company that has positively impacted the lives of over 30 million people across more than 100 countries. Our commitment to innovation drives us to continuously develop and provide cutting-edge solutions that empower individuals on their diabetes management journey. We understand that living with diabetes is a personal experience that comes with many challenges. Hence, we strive to offer not only effective products—such as our high-quality pen needles and syringes—but also the necessary education and resources to help users navigate their diabetes management smoothly. Our mission extends beyond just products; it encompasses a holistic approach to care, ensuring that patients and healthcare providers have the tools they need to succeed. We are dedicated to advancing insulin delivery technology and reshaping the patient experience, reinforcing our legacy of excellence while looking towards a future where every diabetic individual can lead a healthier and fulfilling life.